These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9484873

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
    Schaberg T, Ballin I, Huchon G, Bassaris H, Hampel B, Reimnitz P, AECB Study Group.
    J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Safety profile of grepafloxacin compared with other fluoroquinolones.
    Stahlmann R, Schwabe R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():83-92. PubMed ID: 9484877
    [Abstract] [Full Text] [Related]

  • 49. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin.
    Ferguson J, Dawe R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():93-8. PubMed ID: 9484878
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K, Horiba M, Naide Y, Shinoda M, Hibi H.
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J.
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [Abstract] [Full Text] [Related]

  • 56. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Dec; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Busman TA, Norris S, Notario GF.
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.